Table 3. Univariate Cox regression of overall survival and clinicopathologic characteristics in TCGA OSCC patients.
| Clinical characteristics | Hazard ratio | HR (95% CI) | p-value |
|---|---|---|---|
| Age (≤65 vs. >65) | 1.0201 | 1.0036–1.0368 | 0.01645* |
| Gender (female vs. male) | 0.9552 | 0.6442–1.4163 | 0.81960 |
| Grade (G1/G2/G3) | 1.4248 | 1.0400–1.9518 | 0.02750* |
| Clinical stage (I/II/III/IV) | 1.7425 | 1.3420–2.2625 | 0.00003* |
| T stage (T1/2/3/4) | 1.5236 | 1.2459–1.8631 | 0.00004* |
| N stage (N0/1/2/3) | 1.5317 | 1.2478–1.8802 | 0.00004* |
| IGF2BP2 expression (low/high) | 1.0156 | 1.0013–1.0301 | 0.03151* |
P<0.05 was considered statistically significant.